No7 Lift And Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum Spf 15 Warm Beige
Octinoxate
Bcm Cosmetique Sas
Human Otc Drug
NDC 61589-9505No7 Lift And Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum Spf 15 Warm Beige also known as Octinoxate is a human otc drug labeled by 'Bcm Cosmetique Sas'. National Drug Code (NDC) number for No7 Lift And Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum Spf 15 Warm Beige is 61589-9505. This drug is available in dosage form of Cream. The names of the active, medicinal ingredients in No7 Lift And Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum Spf 15 Warm Beige drug includes Octinoxate - 1.5 g/30g Titanium Dioxide - .5 g/30g . The currest status of No7 Lift And Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum Spf 15 Warm Beige drug is Active.
Drug Information:
| Drug NDC: | 61589-9505 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | No7 Lift And Luminate Triple Action Serum Foundation Sunscreen Broad Spectrum Spf 15 Warm Beige |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Octinoxate |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Bcm Cosmetique Sas |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Cream |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | OCTINOXATE - 1.5 g/30g
TITANIUM DIOXIDE - .5 g/30g
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | TOPICAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 21 Jan, 2018 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 24 Dec, 2025 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Application Number: | part352 |
| This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | BCM Cosmetique SAS
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UNII: | 4Y5P7MUD51
15FIX9V2JP
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 61589-9505-1 | 1 BOTTLE in 1 CARTON (61589-9505-1) / 30 g in 1 BOTTLE | 21 Jan, 2018 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Uses uses - helps prevent sunburn
Product Elements:
No7 lift and luminate triple action serum foundation sunscreen broad spectrum spf 15 warm beige octinoxate octinoxate octinoxate titanium dioxide titanium dioxide water cyclomethicone 5 nylon 612 (mw 14000) glycerin mica dimethicone butylene glycol peg-9 dimethicone cyclomethicone 6 trimethylsiloxysilicate (m/q 0.6-0.8) disteardimonium hectorite magnesium sulfate, unspecified phenoxyethanol .alpha.-tocopherol acetate propylene glycol methylparaben propylene carbonate ethylparaben triethoxycaprylylsilane pentylene glycol ascorbyl glucoside panax ginseng root water carbomer 940 dimethylmethoxy chromanol potassium hydroxide polysorbate 20 xanthan gum tocopherol n-acetyl dipeptide-1 vitamin a palmitate morus alba leaf etidronate tetrasodium palmitoyl tripeptide-1 palmitoyl tetrapeptide-7 ferric oxide yellow ferric oxide red ferrosoferric oxide
Indications and Usage:
Directions directions for suncreen use apply liberally 15 minutes before sun exposure reapply at least every 2 hours use a water resistant sunscreen if swimming or sweating children under 6 months of age: ask a doctor sun protection measures. spending time in the sun increases your risk of skin cancer and early skin aging. to decrease this risk, regularly use a sunscreen with a broad spectrum spf value of 15 or higher and other sun protection measures including: limit time in the sun, especially from 10 a.m. - 2 p.m. wear long-sleeved shirts, pants, hats, and sunglasses
Warnings and Cautions:
Warnings for external use only do not use on damaged or broken skin when using this product keep out of eyes. rinse with water to remove
Warnings warning: avoid contact with eyes. if product gets into the eyes, rinse well with water immediately.
Description:
Description your best looking skin, instantly smoother, firmer and more radiant: lines and wrinkles appear reduced skin looks firmer and more lifted skin tone looks more even enriched with age-defying skincare technology from our highly acclaimed no7 lift and luminate triple action serum:matrixyl 3000 plus tm our most effective anti-wrinkle peptide technology:hibiscus and vitamins a and c to help reduce the appearance of pigmentation. the flexible formula moves with the skin, ensuring it doesn't muigrate into lines and wrinkles. our uhique blend of optical blurrers and light reflecting particles brighten the skin. whilst wearing the product: 97% saw more even skin tone 85% saw reduced fine lines 81% saw firmer skin for best age-defying benefts use together with no7 lift and luminate triple action serum and day cream shake before use. blend on smoothly and evenly with your fingers, sponge or brush
Description no7 lift and luminate triple action serum foundation sunscreen broad spectrum spf 15 3 instant results wrinkles appear reduced skin looks firmer skin tone looks more even radiant finish medium coverage suitable for sensitive skin 30ml e 1 us fl.oz.
Information for Patients:
Information made in france the boots company plc nottingham england ng2 3aa dist. in the usa by boots retail usa inc. new york ny 10005
Package Label Principal Display Panel:
No7lltripleactionserumfoundationcarton